SGLT2 inhibitors and how we use them
Goodfellow Unit
English - February 23, 2021 11:00 - 24 secondsScience Health & Fitness Medicine goodfellow unit primary health care professional practitioner new zealand general Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Transgender physical health
Next Episode: Myelodysplastic Syndrome
In this podcast, Dr Rick Cutfield discusses the management of type two diabetes mellitus following the introduction of new funded medication in NZ.
He covers the importance of lifestyle, medication, and support at every step, and also the pharmacological management including the new stepwise approach to management.
Indications and precautions of the new classes of subsidised medications: Sodium glucose co-transporter 2 (SGLT-2) inhibitors, and briefly Glucagon like peptide-1 receptor (GLP-1) agonists are also covered.